Want to see QNTM full AI Analyst Report?
Quantum Biopharma (QNTM) Financial Statements
Quantum Biopharma Financial Overview
Quantum Biopharma's market cap is currently $19.25M. The company's EPS TTM is $-5.65; its P/E ratio is -0.42; Quantum Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -15.30M | $ -16.14M | $ -23.79M | $ -27.43M | $ -33.74M |
| EBITDA | $ -25.79M | $ -14.38M | $ -15.72M | $ -22.12M | $ -29.82M |
| Net Income | $ -26.18M | $ -14.20M | $ -17.90M | $ -23.61M | $ -35.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.17M | $ 7.20M | $ 3.51M | $ 17.00M | $ 35.42M |
| Total Assets | $ 11.14M | $ 17.12M | $ 17.47M | $ 38.41M | $ 62.96M |
| Total Debt | $ 1.87M | $ 824.92K | $ 339.20K | $ 516.42K | $ 555.90K |
| Net Debt | $ -29.09K | $ -5.17M | $ -2.42M | $ -16.46M | $ -34.70M |
| Total Liabilities | $ 6.05M | $ 6.68M | $ 4.57M | $ 7.87M | $ 8.83M |
| Stockholders' Equity | $ 6.91M | $ 11.48M | $ 13.24M | $ 30.54M | $ 54.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.38M | $ -6.88M | $ -10.83M | $ -28.70M | $ -21.25M |
| Operating Cash Flow | $ -8.38M | $ -6.88M | $ -10.83M | $ -28.33M | $ -20.75M |
| Investing Cash Flow | $ -1.99M | $ -1.50M | $ -269.58K | $ 12.12M | $ 268.96K |
| Financing Cash Flow | $ 6.21M | $ 11.62M | $ -3.13M | $ -2.07M | $ 38.21M |
Currency in CAD